NP / PA
Commonwealth Hematology Oncology PSC
Commonwealth Hematology Oncology PSC was paid $1.88M by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is 78815, Positron emission tomography (PET) for limited area imaging — 34% of everything it billed.
33Billing provider infoCOMMONWEALTH HEMATOLOGY ONCOLOGY PSC
SOMERSET, KY 42503
SOMERSET, KY 42503
33aNPI1285687178assigned 05/19/2006
33bProvider typeFamily Nurse Practitioner
28Total paid$1.88M
24GClaims82,016
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Kentucky
Rank by total paid#9 of 424
Median peer was paid$19K
This provider vs. median100×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,955 | $448K | |
| 2019 | 11,925 | $398K | |
| 2020 | 14,594 | $309K | |
| 2021 | 16,092 | $235K | |
| 2022 | 12,092 | $176K | |
| 2023 | 9,653 | $150K | |
| 2024incomplete | 5,705 | $164K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 78815 | Positron emission tomography (PET) for limited area imaging | 34% | 1,350 | 1,142 | $640K |
| 77014 | 9.7% | 4,735 | 716 | $183K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 7.8% | 3,154 | 1,349 | $146K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 6.2% | 3,573 | 2,702 | $116K |
| 77300 | 5.2% | 584 | 278 | $98K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.8% | 3,470 | 2,860 | $91K |
| 77427 | 4.1% | 1,513 | 607 | $78K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.7% | 17,855 | 10,117 | $70K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.3% | 5,539 | 2,635 | $62K |
| 77334 | 3.2% | 601 | 420 | $60K | |
| 77336 | 2.9% | 1,516 | 605 | $55K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.3% | 3,286 | 1,455 | $42K |
29 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.1% | 5,351 | $39K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.9% | 2,397 | $35K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1.7% | 1,452 | $31K |
| J0897 | Injection, denosumab, 1 mg | <1% | 27 | $17K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 796 | $17K |
| 99205 | Prolong outpt/office vis | <1% | 252 | $14K |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,532 | $13K |
| 77263 | <1% | 223 | $13K | |
| 77280 | <1% | 254 | $12K | |
| 96523 | <1% | 839 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,148 | $6K |
| 96367 | <1% | 393 | $6K | |
| 77387 | <1% | 95 | $6K | |
| 77290 | <1% | 57 | $4K | |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | <1% | 186 | $4K |
| 77417 | <1% | 605 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,635 | $3K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 216 | $2K |
| 96417 | <1% | 24 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,382 | $1K |
| 96415 | <1% | 28 | $830.42 | |
| 96368 | <1% | 81 | $596.68 | |
| 77331 | <1% | 33 | $370.62 | |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | <1% | 156 | $238.90 |
| G6012 | Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | <1% | 96 | $168.08 |
| 36591 | <1% | 1,253 | $157.73 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 89 | $58.92 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 205 | $20.73 |
| 99070 | 0% | 35 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNIAZI, MUHAMMAD (PRESIDENT)